Research Article
Do Statins Have a Positive Impact on Patients with Coronary Microvascular Dysfunction on Long-Term Clinical Outcome? A Large Retrospective Cohort Study
Table 1
Baseline characteristics of the study population and comparison between statin treatment and non-statin treatment.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BMI, Body Mass Index; CKD, chronic kidney disease; AF, atrial fibrillation; AFL, atrial flutter; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; RAAS, renin-angiotensin-aldosterone system; CCB, calcium channel blockers; BUN, urea nitrogen; WBC, white blood cell count; NYHA, New York Heart Association classification; Glu, glucose; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LVEF, left ventricular ejective fraction; RAAS, renin-angiotensin-aldosterone system (RAAS); MACE, Major Adverse Cardiovascular Events |